Non-genomic effects of estrogen and the vessel wall

Biochemical Pharmacology

Volumn 51, Issue 5, 1996, Pages 571-576

  Farhat, Michel Y ^a   Abi Younes, Sylvie ^a   Ramwell, Peter W ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

calcium influx; cyclic AMP; estrogen; non genomic; steroids; vascular reactivity; vascular smooth muscle

Indexed keywords

ALDOSTERONE; CALCIUM; CALCIUM CHANNEL; CYCLIC NUCLEOTIDE; DIETHYLSTILBESTROL; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; GLUCOCORTICOID; PROGESTERONE; VITAMIN D;

BLOOD VESSEL REACTIVITY; BLOOD VESSEL WALL; CALCIUM MOBILIZATION; CELL CULTURE; CELL MEMBRANE; CORONARY ARTERY BLOOD FLOW; FEMALE; HUMAN; ISOLATED ARTERY; NONHUMAN; PERIPHERAL CIRCULATION; POSTMENOPAUSE; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE RELAXATION; VASCULAR SMOOTH MUSCLE; VASODILATATION;

EID: 0029987748     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(95)02159-0     Document Type: Note

References (78)

1. Katzenellenbogen B, Dynamics of steroid hormone receptor action. Annu Rev Physiol 42: 17-35, 1980.
2. Evans R, The steroid and thyroid hormone receptor superfamily. Science 240: 889-895, 1988.
3. Blackmore PF, Beebe SJ, Danforth DR and Alexander NA, Progesterone and 17α-hydroxyprogesterone: Novel stimulators of calcium influx in human sperm. J Biol Chem 265: 1376-1380, 1990.
4. Lan NC, Chen JS, Belelli D, Pritchett DB, Seeburg PH and Gee KW, A steroid recognition site is functionally coupled to an expressed GABA benzodiazepene receptor. Eur J Pharmacol 188: 403-406, 1990.
5. Wehling M, Christ M and Theisen K, Membrane receptors for aldosterone: A novel pathway for mineralocorticoid action. Am J Physiol 263: E974-E979, 1992.
6. Civitelli R, Kim YS, Gunsten SL, Fujimori A, Huskey M, Avioli LV and Hruska KA, Nongenomic activation of the calcium message system by vitamin D metabolites in osteoblast-like cells. Endocrinology 127: 2253-2262, 1990.
7. Lieberherr M and Grosse B, Androgens increase intracellular calcium concentration and inositol 1,4,5-triphosphate and diacylglycerol formation via a pertussis toxin-sensitive G-protein. J Biol Chem 269: 7217-7223, 1994.
8. McEwen B, Non-genomic and genomic effects of steroids on neural activity. Trends Pharmacol Sci 12: 141-147, 1991.
9. Nabekura J, Oomura Y, Minami T, Mizuno Y and Fukuda A, Mechanism of the rapid effect of 17β-estradiol on medial amygdala neurons. Science 233: 226-228, 1986.
10. Pietras RJ and Szego CM, Endometrial cell calcium and oestrogen action. Nature 253: 357-359, 1975.
11. Batra S, Effect of estrogen and progesterone treatment on calcium uptake by the myometrium and smooth muscle of the lower urinary tract. Eur J Pharmacol 127: 37-42, 1986.
12. Aronica SM, Kraus WL and Katzenellenbogen BS, Estrogen action via the cAMP signaling pathway: Stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc Natl Acad Sci USA 91: 8517-8521, 1994.
13. Gisclard V, Miller VM and Vanhoutte PM, Effect of 17β-estradiol on endothelium-dependent responses in the rabbit. J Pharmacol Exp Ther 244: 19-22, 1988.
14. Williams JK, Adams MR and Klopfenstein HS, Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 81: 1680-1687, 1990.
15. Jiang C, Sarrel PM, Poole-Wilson and PA and Collins P, Acute effect of 17β-estradiol on rabbit coronary artery contractile responses to endothelin-1. Am J Physiol 163: H271-H275, 1992.
16. Rhee CY, Spaet TH, Stemerman MB, Lajam F and Shiang HH, Estrogen suppression of surgically induced vascular intimai hyperplasia in rabbits. J Lab Clin Med 90: 77-84, 1977.
17. Foegh ML, Khirabadi BS, Nakanishi T, Vargas R and Ramwell PW, Estradiol protects against experimental cardiac transplant atherosclerosis. Transplant Proc 19: 90-95, 1987.
18. Foegh ML, Asotra S, Howell M and Ramwell PW, Estradiol inhibition of neointimal hyperplasia after balloon injury. J Vasc Surg 19: 722-726, 1994.
19. Ueland K and Parer JT, Effects of estrogens on the cardiovascular system of the ewe. Am J Obstet Gynecol 96: 400-406, 1966.
20. Resnik R, Battaglia F, Makowski E and Meschia G, The effect of actinomycin D on estrogen induced uterine blood flow. Am J Obstet Gynecol 122: 273-277, 1975.
21. Penney L, Frederick R and Parker G, 17β-Estradiol stimulation of uterine blood flow in oophorectomized rabbits with complete inhibition of uterine ribonucleic acid synthesis. Endocrinology 109: 1672-1676, 1981.
22. Williams JK, Adams MR, Herrington DM and Clarkson TB, Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries. J Am Coll Cardiol 20: 452-457, 1992.
23. Gilligan DM, Quyyumi AA and Cannon RO III, Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation 89: 2545-2551, 1994.
24. Reis SE, Gloth ST, Blumenthal RS, Resar JR and Zacur HA, Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation 89: 52-60, 1994.
25. Gilligan DM, Badar DM, Panza JA, Quyyumi AA and Cannon RO III, Acute vascular effects of estrogen in postmenopausal women. Circulation 90: 786-791, 1994.
26. Rosano GMC, Sarrel PM, Poole-Wilson PA and Collins P, Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet 342: 133-136, 1993.
27. 2+ channels in altering uterine blood flow during the estrous cycle and early pregnancy in gilts. Biol Reprod 36, 369-375, 1987.
28. De Sa M and Meirelles R, Vasodilating effect of estrogen on the human umbilical artery. Gynecol Invest 8: 307-313, 1977.
29. Raddino R, Manca C, Poli E, Bolognesi R and Visioli O, Effects of 17β-estradiol on the isolated rabbit heart: Arch Int Pharmocodyn 281: 57-65, 1986.
30. Harder D and Coulson P, Estrogen receptors and effects of es-trogen on membrane electrical properties of coronary vascular smooth muscle. J. Cell Physiol 100: 375-382, 1979.
31. 2+ in guinea-pig isolated cardiac myocytes. Br J Pharmacol 106: 739-745, 1992.
32. 2α mediated contraction of the porcine coronary artery. Adv Prostaglandin Thromboxane Leukot Res 19: 277-280, 1989.
33. Mügge A, Riedel M, Barton M, Kuhn M and Lichtlen PR, Endothelium independent relaxation of human coronary arteries by 17βoestradiol in vitro. Cardiovosc Res 27: 1939-1942, 1993.
34. Futo J, Shay J, Block S, Holt J, Beach M and Moss J, Estrogen and progesterone withdrawal increases cerebral vasoreactivity to serotonin in rabbit basilar artery. Life Sci 50: 1165-1172, 1992.
35. Salas E, Lopez MG, Villarroya M, Sáanchez-García P, De Pascual R, Dixon WR and García AG, Endothelium-independent relaxation by 17-α-estradiol of pig coronary arteries. Eur J Pharmacol 258: 47-55, 1994.
36. +, and U-46619. J Cardiovasc Pharmacol 25: 200-206, 1995.
37. Farhat MY and Ramwell PW, Estradiol potentiates the vasopressor response of the isolated perfused rat lung to the thromboxane mimic U46619. J Pharmacol Exp Ther 261: 686-691, 1992.
38. Ford S and Stice S, Effects of the ovary and conceptus on uterine blood flow in the pig. J Reprod Fertil 33: 83-90, 1985.
39. 2+ currents in A7r5 vascular smooth muscle celt line. Am J Physiol 266: C975-C980, 1994.
40. De Beer EL and Keizer HA, Direct action of estradiol-17β on the atrial action potential. Steroids 40: 223-231, 1982.
41. Morley P, Whitfield JF, Vanderhyden BC, Tsang BK and Schwartz JL, A new nongenomic estrogen action: The rapid release of intracellular calcium. Endocrinology 131: 1305-1312, 1992.
42. Szego C and Davis J, Inhibition of estrogen-induced cyclic AMP elevation in rat uterus by glucocorticoids. Life Sci 8: 1109-1116, 1969.
43. Kishi Y and Numano F, A study of the mechanism of estrogen as an antiatherosclerotic: The inhibitory effect of estrogen on A23187-induced contraction of the aortic wall. Mech Ageing Dev 18: 115-123, 1982.
44. Rosenfeld M and O'Malley B, Steroid hormones: Effects on adenyl cyclase activity and adenosine 3′,5′-monophosphate in target tissues. Science 168: 253-255, 1970.
45. Flandory L and Galand P, Changes in cGMP and cAMP content in the estrogen-stimulated rat uterus: Temporal relationship with other parameters of hormonal stimulation. J Cyclic Nucleotide Res 4: 145-158, 1978.
46. Kuehl FA Jr, Ham EA, Zanetti ME, Sanford CH, Nicol SE and Golberg ND, Estrogen-related increases in uterine guanosine 3′: 5′ cyclic monophosphate levels. Proc Natl Acad Sci USA 71: 1866-1870, 1974.
47. Weissman B, Daly J and Skolnick P, Diethylstilbestrol-elicited accumulation of cyclic AMP in incubated rat hypothalamus. Endocrinology 97: 1559-1566, 1975.
48. Kuehl F Jr, Zanetti ME, Cirillo VJ and Ham EA, Estrogen-induced alterations in cyclic nucleotide and prostaglandin levels in target tissue. J Steroid Biochem 6: 1099-1105, 1975.
49. 125I-bovine serum albumin as a ligand. J Neurochem 54: 467-472, 1990.
50. A receptor. Eur J Pharmacol 189: 307-315, 1990.
51. Wehling M, Eisen C, Aktas J, Christ M and Theisen K, Photoaffinity labeling of plasma membrane receptors for aldosterone from human mononuclear leukocytes. Biochem Biophys Res Commun 189: 1424-1428, 1992.
52. Christ M, Sippel K, Eisen C and Wehling M, Non-classical receptors for aldosterone in plasma membranes from pig kidneys. Mol Cell Endocrinol 99: R31-R34, 1994.
53. 3H-aldosterone. Exp Clin Endocrinol 92: 194-198, 1988.
54. Suyemitsu T and Terayama H, Specific binding sites for natural glucocorticoids in plasma membranes of rat liver. Endocrinology 96: 1499-1508, 1975.
55. Orchinik M, Murray TF and Moore FL, A corticosteroid receptor in neuronal membranes. Science 252: 1848-1851, 1991.
56. 3. J Cell Biochem 56: 510-517, 1994.
57. Pietras RJ and Szego CM, Specific binding sites for oestrogen at the outer surface of isolated endometrial cells. Nature 265: 69-72, 1977.
58. Pietras R and Szego C, Estrogen receptors in uterine plasma membrane. J Steroid Biochem 11: 1471-1483, 1979.
59. Pietras RJ and Szego CM, Metabolic and proliferative responses to estrogen by hepatocytes selected for plasma membrane binding-sites specific for estradiol-17β. J Cell Physiol 98: 145-160, 1979.
60. Pietras RJ and Zsego CM, Partial purification and characterization of estrogen receptors in subfractions of hepatocyte plasma membranes. Biochem J 191: 743-760, 1980.
61. Towle A and Sze P, Steroid binding to synaptic plasma membrane: Differential binding of glucocorticoids and gonadal steroids. J Steroid Biochem 18: 135-143, 1983.
62. Bression D, Michard M, Le Dafniet M, Pagesy P and Peillon F, Evidence for a specific estradiol binding site on rat pituitary membranes. Endocrinology 119: 1048-1051, 1986.
63. Schaeffer J, Stevens S, Smith R and Hsueh A, Binding of 2-hydroxyestradiol to rat anterior pituitary cell membranes. J Biol Chem 255: 9838-9843, 1980.
64. Pappas TC, Gametchu B, Yannariello-Brown J, Collins TJ and Watson CS, Membrane estrogen receptors in GH3/B6 cells are associated with rapid estrogen-induced release of prolactin. Endocrine 2: 813-822, 1994.
65. Nenci I, Marchetti E and Marzola A, Affinity cytochemistry visualizes specific estrogen binding sites on the plasma membrane of breast cancer cells. J Steroid Biochem 14: 1139-1146, 1981.
66. Berthois Y, Pourreau-Schneider N, Gandilhon P, Mittre H, Tubiana N and Martin PM, Estradiol membrane binding sites on human breast cancer cell lines. Use of a fluorescent estradiol conjugate to demonstrate plasma membrane binding systems. J Steroid Biochem 25: 963-972, 1986.
67. Pappas TC, Gametchu B and Watson CS, Membrane estrogen receptors identified by multiple antibody labeling and impeded-ligand binding. FASEB J 9: 404-410, 1995.
68. Thampan TNRV and Clark JH, An estrogen receptor activator protein in rat uterine cytosol. Nature 290: 152-154, 1981.
69. Somlyo AP and Somlyo AV, Signal transduction and regulation in smooth muscle. Nature 372: 231-236, 1994.
70. 2 and cerebral circulation in newborn pigs: Cyclic nucleotides and prostanoids in vascular regulation. Am J Physiol 266: H1494-1501, 1994.
71. Metcalfe JC, Moore JP, Smith GA and Hesketh TR, Calcium and cell proliferation. Br Med Bull 42: 405-412, 1986.
72. 2+ mobilization, by cyclic AMP and GMP in rabbit aortic smooth-muscle cells. Biochem J 288: 527-532, 1992.
73. Cook SJ and McCormick F, Inhibition by cAMP of Ras-dependent activation of Raf. Science 262: 1069-1072, 1993.
74. Wu J, Dent P, Jelinek T, Wolfman A, Weber MJ and Sturgill TW, Inhibition of the EGF activated MAP kinase signalling pathway by adenosine 3′,5′ monophosphate. Science 262: 1065-1069, 1993.
75. Cho H and Katzenellenbogen BS, Synergistic activation of estrogen receptor-mediated transcription by estradiol on protein kinase activators. Mol Endocrinol 7: 441-452, 1993.
76. Fujimoto N and Katzenellenbogen BS, Alteration in the agonist/ antagonist balance of antiestrogens by activation of protein kinase A signaling pathways in breast cancer cells: Antiestrogen selectivity and promotor dependence. Mol Endocrinol 8: 296-304, 1994.
77. Power RF, Mani SK, Codina J, Conneely OM and O'Malley BW, Dopaminergic and ligand-independent activation of steroid hormone receptors. Science 254: 1636-1639, 1991.
78. Wehling M, Nongenomic actions of steroid hormones. Trends Endocrinol Metab 5: 347-353, 1994.